**Job Description**

The Mixed Modalities team is responsible for drug product development small, intermediate, and large molecules from preclinical toxicology studies to commercialization for parenteral and inhaled dosage forms. Our development teams ensure robust composition, primary packaging/device, and process selection through deep fundamental understanding and characterization such that the process is scalable without compromising stability, safety, efficacy, and delivery. During development, we leverage smart experimental design, cutting edge analytical tools, and predictive approaches to inform molecule, formulation, and process selection. In summary, our team enables the translation of preclinical candidates into non-oral drug products.

We are seeking a highly motivated candidate for the position of Principal Scientist with deep subject-matter expertise to lead the design and development of integrated (single-entity) and non-integrated (co‑packaged/cross‑labe...